Free Trial

InfuSystem (NYSE:INFU) Shares Down 2% - Here's Why

InfuSystem logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares of InfuSystem fell about 2% midday to $9.35 (from $9.54) with volume rising ~24% to 166,555 shares, trading below its 200-day moving average of $9.24.
  • Analysts remain positive: Roth MKM reiterated a Buy and raised the price target to $15, and the consensus rating is Buy with an average $15 target (1 Strong Buy, 2 Buy, 1 Hold).
  • InfuSystem is a medical-technology firm that rents and services infusion pumps and is expanding into remote patient monitoring; it has a market cap of $189M, a high P/E (~155.9) and ~71% institutional ownership.
  • MarketBeat previews the top five stocks to own by May 1st.

Shares of InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) dropped 2% during mid-day trading on Monday . The company traded as low as $9.15 and last traded at $9.35. Approximately 166,555 shares changed hands during trading, an increase of 24% from the average daily volume of 134,286 shares. The stock had previously closed at $9.54.

Analyst Ratings Changes

Separately, Roth Mkm restated a "buy" rating and issued a $15.00 price target (up from $14.00) on shares of InfuSystem in a report on Tuesday, February 24th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, InfuSystem has a consensus rating of "Buy" and an average price target of $15.00.

Read Our Latest Stock Report on INFU

InfuSystem Stock Performance

The stock's 50-day moving average price is $8.70 and its 200 day moving average price is $9.24. The firm has a market cap of $189.01 million, a P/E ratio of 155.86 and a beta of 1.66. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59.

Hedge Funds Weigh In On InfuSystem

A number of large investors have recently modified their holdings of the business. Quarry LP bought a new position in shares of InfuSystem in the 4th quarter valued at about $31,000. Raymond James Financial Inc. bought a new stake in InfuSystem during the second quarter worth about $33,000. Virtu Financial LLC bought a new stake in InfuSystem during the fourth quarter worth about $90,000. LPL Financial LLC acquired a new position in InfuSystem during the fourth quarter valued at approximately $92,000. Finally, GK Wealth Management LLC acquired a new position in InfuSystem during the fourth quarter valued at approximately $95,000. 71.13% of the stock is currently owned by institutional investors and hedge funds.

InfuSystem Company Profile

(Get Free Report)

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem's offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in InfuSystem Right Now?

Before you consider InfuSystem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InfuSystem wasn't on the list.

While InfuSystem currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines